Placeholder Banner

BIO Letter to White House on Need for Animal Biotech Reform in Wake of COVID-19

April 7, 2020

As part of the Administration’s comprehensive response to the unprecedented health and economic impacts from the COVID-19 pandemic, the Biotechnology Innovation Organization (BIO) respectfully requests that the U.S. government immediately reform its approach to oversight of animals with intentional genomic alterations. We are calling on the White House to direct the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) to develop and execute a memorandum of understanding (MOU) clarifying regulatory responsibilities over these animals within 30 days.

Download Full Comments Below
BIO Greenwood Letter to President Trump on Animal Biotech
Discover More
BIO understands that consumers want more information about what is in their food and whether their food is safe. Our members will be a driver of that…
In recent years advances in animal genetics have provided significant breakthroughs that can help to address some of society's most difficult challenges. These technologies can treat and protect animals from illness; limit the transmission of…
We support prioritizing the healthcare sector for COVID-19 testing supplies, and as testing becomes more available and abundant, the undersigned organizations urge the federal government to provide COVID-19 testing resources to U.S. employers that…